Material Agreements

Cantor Equity Partners III, Inc. entered into Forward Purchase Agreement with Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP valued at Prepaid share forward transaction for up to 5,000,000 Class A ordinary shares; Prepayment Amount equ (effective 2026-05-11).

“On May 11, 2026, CAEP and Pubco entered into a forward purchase agreement (the “ Forward Purchase Agreement ”) with Harraden Circle Investors, LP (“HCI”), (ii) Harraden Circle Special Opportunities, LP (“HCSO”), (iii) Harraden Circle Strategic Investments, LP (“HCSI”), (iv) Harraden Circle Concentrated, LP (“HCC”) (with HCI, HCSO, HCSI, HCC collectively, as “ Seller ”) for a prepaid share forward transaction.”

MGT CAPITAL INVESTMENTS, INC. entered into Securities Purchase Agreements with several accredited investors valued at up to $500,000 (effective 2026-04-08).

“Between April 8, 2026, and May 5, 2026, MGT Capital Investments, Inc. (the “Company”) entered into Securities Purchase Agreements and related Subscription Agreements (collectively, the “Agreement”) with several accredited investors.”

Hilton Worldwide Holdings Inc. entered into Indenture with Wilmington Trust, National Association valued at $1 billion (effective 2026-05-11).

“On May 11, 2026, Hilton Domestic Operating Company Inc. (the “Issuer”), an indirect subsidiary of Hilton Worldwide Holdings Inc. (the “Company”), issued and sold $1 billion aggregate principal amount of 5.500% Senior Notes due 2031 (the “Notes”) under an Indenture, dated as of May 11, 2026 (the “Indenture”), by and among the Issuer, the Company, as a guarantor, the other guarantors party thereto and Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”).”

Travere Therapeutics, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, Jefferies LLC and Leerink Partners LLC, as representatives of the several underwriters valued at $525.0 million aggregate principal amount of 0.50% Convertible Senior Notes due 2032 (effective 2026-05-11).

“On May 11, 2026 (the “Closing Date”), Travere Therapeutics, Inc. (the “Company”) completed its registered underwritten public offering of $525.0 million aggregate principal amount of 0.50% Convertible Senior Notes due 2032 (such notes, the “Notes,” and such offering, the “Offering”) pursuant to the underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Jefferies LLC and Leerink Partners LLC, as representatives of the several underwriters (the “Underwriters”)”

Picard Medical, Inc. entered into Placement Agency Agreement with WestPark Capital, Inc. valued at 7.0% of the gross proceeds of the Offering (effective 2026-05-05).

“WestPark Capital, Inc. acted as the sole placement agent (the “Placement Agent”) in connection with the Offering pursuant to a placement agency agreement, dated May 5, 2026, by and between the Company and the Placement Agent (the “Placement Agency Agreement”).”

Picard Medical, Inc. entered into Purchase Agreement with certain investors valued at aggregate of approximately $5.0 million (effective 2026-05-05).

“Certain of the investors purchased their Offered Shares and Common Warrants pursuant to a securities purchase agreement dated May 5, 2026 by and among the Company and such investors (the “ Purchase Agreement ”).”

KINGSWAY FINANCIAL SERVICES INC entered into Membership Interest Purchase Agreement with Trinity Warranty Holding LLC valued at $5 million, paid in cash ... and $3 million payable in the form of secured subordinated promissory n (effective 2026-05-08).

“On May 8, 2026, Kingsway Warranty Holdings LLC (“ Kingsway Seller ”), a wholly owned subsidiary of Kingsway Financial Services Inc. (“ Kingsway ”), entered into a Membership Interest Purchase Agreement (the “ Purchase Agreement ”) with Trinity Warranty Holding LLC (“ Buyer ”), pursuant to which, subject to the terms and conditions of the Purchase Agreement, Kingsway Seller sold to Buyer all of the issued and outstanding equity interests (the “ Company Equity ”) of Trinity Warranty Solutions LLC”

BuzzFeed, Inc. entered into Stock Purchase Agreement with Allen Family Digital, LLC valued at $120.0 million (effective 2026-05-11).

“BuzzFeed, Inc. (the "Company") entered into a Stock Purchase Agreement (the "Stock Purchase Agreement") with Allen Family Digital, LLC (the "Investor"), pursuant to which the Company agreed to issue and sell to the Investor, 40,000,000 shares (the "Shares") of the Company's Class A common stock, par value $0.0001 per share (the "Class A common stock"), at a purchase price of $3.00 per share of Class A common stock, for aggregate consideration of $120.0 million”

Navitas Semiconductor Corp entered into Sales Agreement with Craig-Hallum Capital Group LLC and UBS Securities LLC valued at $125.0 million (effective 2026-05-11).

“On May 11, 2026, Navitas Semiconductor Corporation, a Delaware corporation (the “ Company ”), entered into a Sales Agreement (the “ Sales Agreement ”) with Craig-Hallum Capital Group LLC and UBS Securities LLC (together, the “ Sales Agents ”).”

Booking Holdings Inc. entered into Agency Agreement with U.S. Bank Europe DAC, UK Branch and U.S. Bank Trust Company, National Association (effective 2026-05-11).

“Pursuant to an Agency Agreement dated as of May 11, 2026 (the “ Agency Agreement ”) relating to the Senior Notes, the Company has appointed U.S. Bank Europe DAC, UK Branch, to act as paying agent for the Senior Notes and U.S. Bank Trust Company, National Association to act as transfer agent for the Senior Notes.”

Booking Holdings Inc. entered into Officers’ Certificates with U.S. Bank Trust Company, National Association valued at €600,000,000 aggregate principal amount of the Company’s 3.500% Senior Notes due 2030, €700,000,000 (effective 2026-05-11).

“Booking Holdings Inc. (the “ Company ”) executed three Officers’ Certificates (the “ Officers’ Certificates ”), in accordance with Sections 2.02 and 10.04 of the Indenture dated August 8, 2017 (the “ Base Indenture ” and, together with the Officers’ Certificates, the “ Indenture ”) between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “ Trustee ”) and registrar, in connection with the sale of €600,000,000 aggregate principal amount of the Company’s 3.500% Senior Notes due 2030 (the “ 2030 Notes ”), €700,000,000 aggregate principal amount of the Company’s 4.000% Senior Notes due 2034 (the “ 2034 Notes ”), and €600,000,000 aggregate principal amount of the Company’s 4.500% Senior Notes due 2039 (the “ 2039 Notes ” and, together with the 2030 Notes and the 2034 Notes, the “ Senior Notes ”).”

Hyperscale Data, Inc. entered into Appendix with AGIBOT PTE. LTD. valued at up to approximately $13.4 million (effective 2026-05-09).

“On May 9, 2026, Hyperscale Data, Inc., a Delaware corporation (the “ Company ”), through its wholly-owned subsidiary, Omnipresent Robotics LLC, a Nevada limited liability company (the “ Omnipresent ”), entered into a definitive Appendix (the “ Appendix ”) with AGIBOT PTE. LTD., a Singaporean company (“ AGIBOT ”), which supplements that certain Partner Agreement dated April 15, 2026 (the “ Partner Agreement ”) entered into by and between Omnipresent and AGIBOT.”

Vernal Capital Acquisition Corp. entered into Underwriting Agreement with D. Boral Capital LLC valued at Underwriting agreement for IPO of 10,000,000 units at $10.00 per unit, total gross proceeds $100,000 (effective 2026-05-05).

“● An Underwriting Agreement, dated May 5, 2026, by and between the Company and D. Boral Capital LLC, as representative of the underwriters”

Odyssey Therapeutics, Inc. entered into Share Purchase Agreement with TPG LSI Rise Orazio II, L.P. (effective 2026-05-07).

“On May 7, 2026, Odyssey Therapeutics, Inc. (the " Company ") entered into a Share Purchase Agreement (the " Purchase Agreement ") with TPG LSI Rise Orazio II, L.P. (" Purchaser "), an affiliate of an existing stockholder of the Company, for the purchase of an aggregate of 1,388,889 shares (the " Shares ") of the Company’s common stock, par value $0.001 (the " Common Stock "), at a per share price equal to the initial public offering price of $18.00 per share, through a private placement financing (the " Private Placement "), which closed concurrently with the initial public offering of shares of the Company’s Common Stock (the " IPO ").”

ZoomInfo Technologies Inc. amended Credit Agreement Amendment to First Lien Credit Agreement with Morgan Stanley Senior Funding, Inc. valued at incr. revolver by $26M to $276M (effective 2026-05-08).

“On May 8, 2026, ZoomInfo LLC (the "Borrower") entered into an amendment (the "Credit Agreement Amendment"), by and among the Borrower, ZoomInfo Technologies LLC, as the co-borrower (the "Co-Borrower"), ZoomInfo Midco LLC ("Holdings"), the other guarantors party thereto, and Morgan Stanley Senior Funding, Inc., as administrative agent, to the Borrower's existing First Lien Credit Agreement, dated as of February 1, 2019, by and among the Borrower, the Co-Borrower, Holdings, the lenders from time to time party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (as amended from time to time, the "First Lien Credit Agreement"), that provided for, among other things, an incremental revolving credit commitment increase in the aggregate principal amount of $26,000,000, bringing the aggregate principal amount of total revolving credit commitments under the First Lien Credit Agreement to $276,000,000.”

ARES CAPITAL CORP entered into Sixth Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $800,000,000 aggregate principal amount (effective 2026-05-11).

“On May 11, 2026 Ares Capital Corporation (the “Company”) and U.S. Bank Trust Company, National Association (the “Trustee”), entered into a Sixth Supplemental Indenture (the “Sixth Supplemental Indenture”) to the Indenture, dated May 13, 2024, between the Company and the Trustee (the “Base Indenture” and, together with the Sixth Supplemental Indenture, the “Indenture”).”

Viridian Therapeutics, Inc.\DE entered into Indenture with U.S. Bank Trust Company, National Association valued at $250,000,000 aggregate principal amount (effective 2026-05-11).

“On May 11, 2026, Viridian Therapeutics, Inc. (the “Company”) completed its public offering (the “Convertible Notes Offering”) of $250,000,000 aggregate principal amount of its 1.75% Convertible Senior Notes due 2032 (the “Notes”), including the exercise in full of the underwriters’ option to purchase up to an additional $25.0 million aggregate principal amount of the Notes, solely to cover over-allotments. The Notes were issued pursuant to, and are governed by, an indenture (the “Base Indenture”), dated as of May 11, 2026, between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), as supplemented by a first supplemental indenture (the “Supplemental Indenture,” and the Base Indenture, as supplemented by the Supplemental Indenture, the “Indenture”), dated as of May 11, 2026, between the Company and the Trustee.”

MCGRATH RENTCORP entered into Third Amended and Restated Credit Agreement with Bank of America, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, BofA Securities, Inc., as Joint Lead Arranger and Sole Bookrunner, U.S. Bank N.A. and Wells Fargo Bank, N.A. as Joint Lead Arrangers and Co-Syndication Agents, and a syndicate of other lenders valued at $725,000,000 (effective 2026-05-08).

“On May 8, 2026, McGrath RentCorp, a California corporation (the “Company”), entered into a Third Amended and Restated Credit Agreement”

Udemy, Inc. terminated Credit Agreement with Citibank, N.A., as administrative agent and collateral agent valued at $200 million secured revolving loan facility.

“Udemy terminated its credit agreement, dated May 30, 2025 (the "Credit Agreement"), by and among Udemy, as the borrower, certain subsidiaries of Udemy from time to time party thereto as guarantors, the lenders named therein, the other financial institutions party thereto, and Citibank, N.A., as administrative agent and collateral agent, and all other agreements related thereto.”

UMH PROPERTIES, INC. amended Third Amended and Restated Credit Agreement with BMO Capital Markets Corp., JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. valued at $260 million in available borrowings with a $340 million accordion feature (effective 2026-05-07).

“On May 7, 2026, UMH Properties, Inc. (“UMH” or the “Company”) entered into a Third Amended and Restated Credit Agreement (the Amendment” or the “Amended Facility”) to amend and extend its existing unsecured revolving credit facility”

QUEST DIAGNOSTICS INC entered into Indenture with The Bank of New York Mellon valued at $500,000,000 aggregate principal amount (effective 2026-05-06).

“On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).”

CONSOLIDATED EDISON INC entered into Equity Distribution Agreement with Barclays Capital Inc., BNY Mellon Capital Markets, LLC, BofA Securities, Inc., CIBC World Markets Corp., Jefferies LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC and Wells Fargo Securities, LLC (as Sales Ag valued at up to an aggregate sales price of $2,000,000,000 (effective 2026-05-08).

“On May 8, 2026, Consolidated Edison, Inc. (“Con Edison” or the “Company”) entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Barclays Capital Inc., BNY Mellon Capital Markets, LLC, BofA Securities, Inc., CIBC World Markets Corp., Jefferies LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC and Wells Fargo Securities, LLC, each in its capacity as agent for the Company (each, a “Sales Agent” and collectively, the “Sales Agents”) and Barclays Bank PLC, The Bank of New York Mellon, Bank of America, N.A., Canadian Imperial Bank of Commerce, Jefferies LLC, JPMorgan Chase Bank, N.A., KeyBanc Capital Markets Inc., Mizuho Markets Americas LLC, The Bank of Nova Scotia, The Toronto-Dominion Bank and Wells Fargo Bank, National Association or their respective affiliates, each in its capacity as forward purchaser (each, a “Forward Purchaser” and collectively, the “Forward P”

LANTRONIX INC entered into Sales Agreement with Needham & Company, LLC and Canaccord Genuity LLC valued at up to $30,000,000 aggregate offering price of common stock (effective 2026-05-08).

“On May 8, 2026, Lantronix, Inc. (the "Company") entered into a Sales Agreement (the "Sales Agreement") with Needham & Company, LLC ("Needham") and Canaccord Genuity LLC ("Canaccord"), with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the "Common Stock"), having an aggregate offering price of up to $30,000,000 (the "Shares"), through either of Needham and Canaccord, each as its sales agent (together, the "Sales Agents").”

PEDEVCO CORP amended Second Amendment to Credit Agreement with Citibank, N.A., as administrative agent valued at Amended EBITDAX definition, borrowing base redetermination schedule, and reserve report delivery sch (effective 2026-05-05).

“On May 5, 2026 (the “Second Amendment Effective Date”), PEDEVCO Corp., a Texas corporation (the “Company”), entered into a Second Amendment to Credit Agreement (the “Second Amendment”) with Citibank, N.A., as administrative agent (the “Administrative Agent”), each of the guarantors party thereto, and each of the lenders party thereto.”

Cellectar Biosciences, Inc. entered into Registration Rights Agreement with certain investors (effective 2026-05-04).

“on May 4, 2026, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with certain investors”

Cellectar Biosciences, Inc. entered into Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. (effective 2026-05-04).

“on May 4, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”)”

Cellectar Biosciences, Inc. entered into Management Purchase Agreement with certain members of the executive management team of the Company (effective 2026-05-04).

“pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement””

Cellectar Biosciences, Inc. entered into Investor Purchase Agreement with certain institutional investors (effective 2026-05-04).

“On May 4, 2026, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement with certain institutional investors (the “Investor Purchaser Agreement”)”

PROSPECT CAPITAL CORP entered into Equity Distribution Agreement with A.G.P. / Alliance Global Partners valued at $400,000,000 (effective 2026-05-08).

“On May 8, 2026, Prospect Capital Corporation (the “Company”) entered into an equity distribution agreement (the “Equity Distribution Agreement”), dated May 8, 2026, with Prospect Capital Management L.P., Prospect Administration LLC and A.G.P. / Alliance Global Partners (together with any additional sales agents that may be added under the Equity Distribution Agreement from time to time, the “Sales Agents”).”

Live Nation Entertainment, Inc. entered into Note Purchase Agreement, Master Trust Indenture, and First Supplemental Indenture with Mount Street Mortgage Servicing Limited, HSBC Bank USA, N.A. valued at €610,000,000 fixed rate senior secured notes (effective 2026-05-08).

“On May 8, 2026, Live Nation VenueCo, LLC (“VenueCo”), a bankruptcy-remote, special purpose vehicle owned by certain bankruptcy-remote, special purpose entities (the “Participants”), which are indirect subsidiaries of Live Nation Entertainment, Inc. (the “Company”), closed its previously announced issuance of €610 million aggregate principal amount of fixed rate senior secured notes (the “Notes”).”

HNO International, Inc. entered into Securities Purchase Agreement with Monroe Street Capital Partners, LP valued at $67,500 (effective 2026-05-05).

“On May 5, 2026, HNO International, Inc. (the "Company") entered into a Securities Purchase Agreement (the "MSC Purchase Agreement") with Monroe Street Capital Partners, LP, a Delaware limited partnership (the "MSC Buyer"), pursuant to which the Company issued to the MSC Buyer a Convertible Promissory Note in the principal amount of $67,500”

TWO HARBORS INVESTMENT CORP. amended Second Amendment to the Agreement and Plan of Merger with CrossCountry Intermediate Holdco, LLC and CrossCountry Merger Corp. valued at $12.00 per share (effective 2026-05-07).

“On May 7, 2026, Two Harbors Investment Corp. (“Two Harbors”) entered into a Second Amendment to the Agreement and Plan of Merger (the “Second Amendment”), by and among Two Harbors, CrossCountry Intermediate Holdco, LLC (“CCM”) and CrossCountry Merger Corp., a wholly owned subsidiary of CCM (“Merger Sub”), to amend the terms of the previously disclosed Agreement and Plan of Merger, dated March 27, 2026 (the “Original CCM Merger Agreement”), as amended by the First Amendment to the Agreement and Plan of Merger, dated April 28, 2026 (the “First Amendment”), by and among Two Harbors, CCM and Merger Sub (the Original CCM Merger Agreement, as amended by the First Amendment and the Second Amendment, the “Amended CCM Merger Agreement”).”

Knight-Swift Transportation Holdings Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $1.5 billion aggregate principal amount (effective 2026-05-08).

“On May 8, 2026, Knight-Swift Transportation Holdings Inc. (the "Company") completed its previously announced private offering (the "Offering") of $1.5 billion aggregate principal amount of 1.00% Convertible Senior Notes due 2031 (the "Notes"), including the exercise in full of the initial purchasers' option to purchase up to an additional $200.0 million principal amount of the Notes.”

Contango Silver & Gold Inc. terminated Lease Agreement with Alaska Hardrock Inc. (effective 2026-05-04).

“(“Contango” or the “Company”), entered into a purchase and sale agreement (the “Purchase Agreement”) and executed a promissory note (the “Promissory Note”) with Alaska Hardrock Inc. (“AHI”) to acquire 100% ownership of the Company’s Lucky Shot project, located in the Willow Mining District about 75 miles north of Anchorage, Alaska (“Lucky Shot”).”

Contango Silver & Gold Inc. entered into Purchase Agreement with Alaska Hardrock Inc. valued at $16,074,000 (effective 2026-05-04).

“On May 4, 2026, Contango Lucky Shot Alaska, LLC (“LSA”), a wholly-owned subsidiary of Contango Silver & Gold Inc. (“Contango” or the “Company”), entered into a purchase and sale agreement (the “Purchase Agreement”) and executed a promissory note (the “Promissory Note”) with Alaska Hardrock Inc. (“AHI”) to acquire 100% ownership of the Company’s Lucky Shot project”

Citius Pharmaceuticals, Inc. amended Third Amendment to Promissory Note with Citius Oncology, Inc. (effective 2026-05-04).

“the Company and Citius Oncology entered into a Third Amendment to Promissory Note (the “Third Amendment”), which amends the promissory note, dated August 16, 2024, as previously amended on September 10, 2025 and December 10, 2025, issued by the Citius Oncology to the Company in the original principal amount of $3,800,111 (the “Promissory Note”)”

Chiron Real Estate Inc. entered into Investor Rights Agreement with Purchasers (including Maewyn XRN LP and others) (effective 2026-05-06).

“In connection with the Private Placement, on May 6, 2026, the Company and the Purchasers entered an Investor Rights Agreement.”

Chiron Real Estate Inc. entered into Investment Agreement with Maewyn XRN LP and other purchasers valued at up to $100.0 million (effective 2026-05-06).

“On May 6, 2026, Chiron Real Estate Inc. (the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with Maewyn XRN LP (the “Maewyn Purchaser”) and each other purchaser that may become a party to this Investment Agreement from time to time (collectively, the “Purchasers”). Pursuant to the Investment Agreement, the Company agreed to issue and sell to the Purchasers a total of 1,000,000 shares of a new series of 6.00% Series C Convertible Perpetual Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), at a purchase price of $100.00 per share, for aggregate gross proceeds of up to $100.0 million (the “Commitment Amount”) (the “Private Placement”).”

National Healthcare Properties, Inc. entered into PSA with an affiliated third party valued at approximately $528 million (effective 2026-05-04).

“On May 4, 2026, National Healthcare Properties, Inc. (the “Company”) and certain of its subsidiaries entered into a definitive purchase and sale agreement (the “PSA”) with an affiliated third party to sell a portfolio of 86 outpatient medical facilities for approximately $528 million”

Via Renewables, Inc. amended amended and restated subordinated promissory note (Note No. 9) with Retailco, LLC valued at up to $25.0 million.

“In connection with entering into the Credit Agreement, the Company entered into an amended and restated subordinated promissory note (Note No. 9) (the “Subordinated Debt Facility”) with Spark HoldCo and Retailco, LLC (“Retailco”).”

Via Renewables, Inc. entered into Credit Agreement with Bank OZK valued at up to $300.0 million (effective 2026-05-06).

“On May 6, 2026, Via Renewables, Inc., a Delaware corporation (the “Company”), and Spark Holdco, LLC (“Spark Holdco”, and together with certain subsidiaries of the Company and Spark Holdco, the “Co-Borrowers”) entered into a Credit Agreement (the “Credit Agreement”), with Bank OZK, as administrative agent (the “Agent”), swing bank, swap bank, issuing bank, joint-lead arranger, sole bookrunner and syndication agent.”

AMERICAN REBEL HOLDINGS INC entered into Exchange Agreement with Streeterville (effective 2026-05-05).

“Streeterville Series E Preferred Exchange Agreements On April 30, 2026, the Company entered into three Exchange Agreements (the “Exchanges”) with Streeterville.”

AMERICAN REBEL HOLDINGS INC entered into Exchange Agreements with Streeterville (effective 2026-04-30).

“Streeterville Series E Preferred Exchange Agreements On April 30, 2026, the Company entered into three Exchange Agreements (the “Exchanges”) with Streeterville.”

Industrial Logistics Properties Trust terminated a credit facility with Citi Real Estate Funding Inc., UBS AG New York Branch, Bank of America, N.A., Bank of Montreal and Morgan Stanley Bank, N.A. valued at $1.4 billion (effective 2026-05-08).

“and then terminated the agreement governing the floating rate mortgage loan in accordance with its terms and without penalty.”

Industrial Logistics Properties Trust entered into a credit facility with Wells Fargo Bank, National Association, Citi Real Estate Funding Inc., Morgan Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch valued at $1.62 billion (effective 2026-05-08).

“On May 8, 2026, certain subsidiaries of our consolidated joint venture, Mountain Industrial REIT LLC, or Mountain JV, entered into a mortgage loan agreement with Wells Fargo Bank, National Association, Citi Real Estate Funding Inc., Morgan Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch, or collectively, the lenders, pursuant to which Mountain JV obtained, in aggregate, a $1.62 billion loan secured by 90 of its properties, or the Loan.”

AVAI BIO, INC. terminated Joint Venture and License Agreement with Ainnova Tech Inc. valued at No termination penalties or further financial obligations will be incurred by either party. (effective 2026-05-07).

“On May 7, 2026, Avai Bio, Inc., formerly known as Avant Technologies Inc. (the “Company” or “AVAI”), and Ainnova Tech Inc. (“Ainnova” or “AINN”) entered into a Mutual Termination Agreement (the “Termination Agreement”) to terminate, by mutual consent, the Joint Venture and License Agreement dated November 8, 2024 (effective as of November 11, 2024) (the “License Agreement”).”

BridgeBio Pharma, Inc. terminated Equity Distribution Agreement, dated May 4, 2023 with Goldman Sachs & Co. LLC and Leerink Partners LLC (formerly known as SVB Securities LLC) (effective 2026-05-07).

“On May 7, 2026, in connection with entering into the Agreement, the Company agreed with Goldman Sachs and Leerink Partners (formerly known as SVB Securities LLC), to terminate that certain Equity Distribution Agreement, dated May 4, 2023, by and among the Company, Goldman Sachs and Leerink Partners, effective as of May 7, 2026.”

BridgeBio Pharma, Inc. entered into Equity Distribution Agreement with Goldman Sachs & Co. LLC and Leerink Partners LLC valued at $500,000,000 (effective 2026-05-07).

“On May 7, 2026, the Company entered into an Equity Distribution Agreement (the “Agreement”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) and Leerink Partners LLC (“Leerink Partners”, and together with Goldman Sachs, the “Sales Agents”) with respect to an “at-the-market” offering program under which the Company may issue and sell, from time to time at its sole discretion and pursuant to a prospectus supplement, shares of its common stock, par value $0.001 per share (“Common Stock”), having an aggregate offering price of up to $500,000,000 (the “Placement Shares”), through the Sales Agents.”

Stardust Power Inc. entered into At Market Issuance Sales Agreement with B. Riley Securities, Inc. valued at $5,000,000 (effective 2026-05-08).

“On May 8, 2026, Stardust Power Inc. (the “Company”) entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”). Pursuant to the terms of the Sales Agreement, the Company may sell from time to time through the Agent, shares of the Company’s common stock, par value $0.0001 per share, having an aggregate offering price of up to $5,000,000 (the “Shares”).”

Sono Group N.V. entered into Share Purchase and Transfer Agreement with Vorratsla-160 M UG, Vorratsla-161 M UG, and Sono Motors GmbH valued at €1.00 in the aggregate (effective 2026-05-04).

“On May 4, 2026 (the “Signing Date”), the Company entered into a Share Purchase and Transfer Agreement (the “SPA”) with (i) Vorratsla-160 M UG (haftungsbeschränkt), a German limited liability company whose sole shareholder is Denis Azhar, and (ii) Vorratsla-161 M UG (haftungsbeschränkt), a German limited liability company whose sole shareholder is Jan Schiermeister (together, the “Purchasers”), and Sono Motors GmbH, a German limited liability company (“Sono Motors”).”